CRN responds to FDA's Review of the Oral Toxicity of Cannabidiol (CBD)
FDA has access to safety data that is absolutely relevant to the ingredients intended for use in dietary supplements at levels that would be commonly used in supplement products, but has repeatedly disregarded this evidence CRN noted in a letter to the agency...